Attract talent

Kura Oncology



Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Our small-molecule drug candidates target signaling pathways and other drivers of cancer where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment.


Add photos to showcase Kura Oncology’s culture


Add Kura Oncology’s values

Insider experiences

Share your experience of working at Kura Oncology

Troy Wilson
President & CEO
Kathleen Ford
Chief Operating Officer
Kirsten Flowers
Chief Commercial Officer
Stephen Dale
Chief Medical Officer
Mollie Leoni
SVP, Clinical Development
George Dimitrov
VP, Pharmacovigilance and Drug Safety
Brandy Lewis
VP, Quality Assurance
Francis Burrows
VP, Translational Research
Roger Bakale
VP, Head of CMC, Clinical and Commercial Manufacturing
Maureen Clancy
VP & Global Head of Program Leadership & Project Management
Tom Doyle
SVP, Finance & Accounting
Teresa Bair
Chief Legal Officer
Pete De Spain
SPV, Investor Relations & Corporate Communications

Add your teams to show how people work together at Kura Oncology

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.